Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

BSX Secures JV Partner & Funding for Ta...

Basin Energy LtdAcquires Extensive Uranium and Rare Earth...

Acquires Extensive Uranium and Rare Earth Portfolio

Basin Energy LtdInvestor Webinar and Presentation

Corazon Mining

Tavi Costa: Gold’s Next Catalyst, Silver’s Path to...